Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples